Catapult Ventures has appointed Chris Spencer as a Venture Partner with the firm’s GM&C Life Sciences Fund.
Spencer, who becomes the Fund’s fourth Venture Partner, will assess investment opportunities and work with the Fund’s smaller investments to help companies successfully grow, with a particular focus on digital health.
Catapult CEO, Nick Wright, says: “I am delighted to welcome Chris to Catapult as a Venture Partner specialising in digital health. Chris has been working with Catapult as our Digital Health Advisor for several months and his insights were invaluable during our investment in Gendius in September this year. Digital convergence in healthcare is an area Catapult is particularly excited about and having someone of Chris’s calibre in the team will help us make even better, more informed investment decisions.”
Spencer says: “I am delighted to be expanding my role with Catapult Ventures and the GM&C Life Sciences Fund helping to advance not only digital health generally but also with a particular link to the North of England.”
